StockTake: Albion Resources
Albion Resources has begun on several thousand metres of planned drilling in WA’s highly prospective Yandal Greenstone Belt.
Stockhead
Long Shortz: Optiscan Imaging
Optiscan has partnered with Long Grove Pharmaceuticals to see Long Grove’s AK-FOUR used in combination with OIL’s tech.
Rise and Shine: Everything you need to know before the ASX opens
Good morning, and Happy Tuesday to you all! Here’s everything you need (and some stuff you don’t need) to know before the ASX opens today.
All you need to know before the ASX opens
Good morning! Here’s everything you need to know before the ASX opens today.
More Stories
Break it Down: Astral Resources
Astral Resources has completed a PFS for its Mandilla gold project, highlighting strong economics amid a record gold price.
TKM expands Christmas Creek drilling
Trek Metals has secured a diamond rig to carry out deeper drilling in parallel with RC drilling at its Christmas Creek gold project.
StockTake: Brightstar Resources
Brightstar Resources have signed a MoU with Paddington Gold to purchase ore from its Menzies gold project in WA.
ASE highlights extensive, high-grade lithium
Astute Metals drilling returns consistently high-grade lithium intersections at its Red Mountain project in Nevada.
CR3 to start uranium drilling at Cummins
Core Energy Minerals will drill an initial 50 aircore holes to target the prospective paleo-sedimentary horizon at its Cummins uranium project in South Australia.
‘Genius Act’ sets stage for crypto growth
The US Senate’s approval of landmark stablecoin legislation could unlock the next wave of institutional investment in crypto, says DigitalX.
ADX’s shallow gas push is a likely winner
ADX Energy’s focus on testing shallow gas prospects in Austria has led Auctus Advisors to maintain its 30c price target.
Report points to BRX valuation uplift
A recent research report has given Belararox a target share price of 44 cents and market cap of $60m based on its copper projects.
Broker initiates on goldie
Canaccord Genuity has initiated on WA gold developer Ausgold with a $1.60 price target, more than double is current price ahead of a DFS.
Dengue surges as climate change bites
If Island Pharma’s drug keeps delivering in clinical trials, it could fast track approval and make a real difference in the fight against dengue.
Original URL: https://www.goldcoastbulletin.com.au/business/stockhead/page/4